Bristol Myers Squibb, colosso farmaceutico con sede principale negli Stati Uniti, ha annunciato un secondo NVIDIA DGX SuperPOD basato su otto sistemi DGX Vera Rubin NVL72 che sar� accessibile da tutte le sedi distribuite a livello mondiale

The pharmaceutical company has demonstrated how AI can transform how drugs discovery and is now scaling AI across R&D to accelerate the discovery of next-generation medicines.

NEW YORK, July 20 : Bristol Myers Squibb said on Monday it is buying the latest-generation computing system from chip company Nvidia to support its use of artificial intelligence…